207 related articles for article (PubMed ID: 32665355)
21. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
[TBL] [Abstract][Full Text] [Related]
22. Role of RAD51AP1 in homologous recombination DNA repair and carcinogenesis.
Pires E; Sung P; Wiese C
DNA Repair (Amst); 2017 Nov; 59():76-81. PubMed ID: 28963981
[TBL] [Abstract][Full Text] [Related]
23. Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells.
Du L; Liu X; Ren Y; Li J; Li P; Jiao Q; Meng P; Wang F; Wang Y; Wang YS; Wang C
Theranostics; 2020; 10(21):9458-9476. PubMed ID: 32863939
[No Abstract] [Full Text] [Related]
24. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F
Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092
[TBL] [Abstract][Full Text] [Related]
25. Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.
Chudasama D; Bo V; Hall M; Anikin V; Jeyaneethi J; Gregory J; Pados G; Tucker A; Harvey A; Pink R; Karteris E
Carcinogenesis; 2018 Mar; 39(3):407-417. PubMed ID: 29126163
[TBL] [Abstract][Full Text] [Related]
26. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer.
Luo ML; Gong C; Chen CH; Lee DY; Hu H; Huang P; Yao Y; Guo W; Reinhardt F; Wulf G; Lieberman J; Zhou XZ; Song E; Lu KP
Cancer Res; 2014 Jul; 74(13):3603-16. PubMed ID: 24786790
[TBL] [Abstract][Full Text] [Related]
27. NUCKS1 is a novel RAD51AP1 paralog important for homologous recombination and genome stability.
Parplys AC; Zhao W; Sharma N; Groesser T; Liang F; Maranon DG; Leung SG; Grundt K; Dray E; Idate R; Østvold AC; Schild D; Sung P; Wiese C
Nucleic Acids Res; 2015 Nov; 43(20):9817-34. PubMed ID: 26323318
[TBL] [Abstract][Full Text] [Related]
28. The DNA-binding activity of USP1-associated factor 1 is required for efficient RAD51-mediated homologous DNA pairing and homology-directed DNA repair.
Liang F; Miller AS; Tang C; Maranon D; Williamson EA; Hromas R; Wiese C; Zhao W; Sung P; Kupfer GM
J Biol Chem; 2020 Jun; 295(24):8186-8194. PubMed ID: 32350107
[TBL] [Abstract][Full Text] [Related]
29. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
Ring A; Kaur P; Lang JE
BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
[TBL] [Abstract][Full Text] [Related]
30. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
31. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
[TBL] [Abstract][Full Text] [Related]
32. Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo.
Ramovs V; Secades P; Song JY; Thijssen B; Kreft M; Sonnenberg A
Breast Cancer Res; 2019 May; 21(1):63. PubMed ID: 31101121
[TBL] [Abstract][Full Text] [Related]
33. MiR-4319 Suppress the Malignancy of Triple-Negative Breast Cancer by Regulating Self-Renewal and Tumorigenesis of Stem Cells.
Chu J; Li Y; Fan X; Ma J; Li J; Lu G; Zhang Y; Huang Y; Li W; Huang X; Fu Z; Yin Y; Yuan H
Cell Physiol Biochem; 2018; 48(2):593-604. PubMed ID: 30021199
[TBL] [Abstract][Full Text] [Related]
34. Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment.
Fang WB; Yao M; Brummer G; Acevedo D; Alhakamy N; Berkland C; Cheng N
Oncotarget; 2016 Aug; 7(31):49349-49367. PubMed ID: 27283985
[TBL] [Abstract][Full Text] [Related]
35. Mahanine, A dietary phytochemical, represses mammary tumor burden in rat and inhibits subtype regardless breast cancer progression through suppressing self-renewal of breast cancer stem cells.
Das M; Kandimalla R; Gogoi B; Dutta KN; Choudhury P; Devi R; Dutta PP; Talukdar NC; Samanta SK
Pharmacol Res; 2019 Aug; 146():104330. PubMed ID: 31251988
[TBL] [Abstract][Full Text] [Related]
36. miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis.
Liu B; Du R; Zhou L; Xu J; Chen S; Chen J; Yang X; Liu DX; Shao ZM; Zhang L; Yu Z; Xie N; Guan JL; Liu S
Theranostics; 2018; 8(21):5801-5813. PubMed ID: 30613263
[TBL] [Abstract][Full Text] [Related]
37. E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer.
López-Menéndez C; Vázquez-Naharro A; Santos V; Dubus P; Santamaría PG; Martínez-Ramírez Á; Portillo F; Moreno-Bueno G; Faraldo MM; Cano A
Cancer Res; 2021 Sep; 81(17):4529-4544. PubMed ID: 34145034
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic insights into RAD51-associated protein 1 (RAD51AP1) action in homologous DNA repair.
Dunlop MH; Dray E; Zhao W; San Filippo J; Tsai MS; Leung SG; Schild D; Wiese C; Sung P
J Biol Chem; 2012 Apr; 287(15):12343-7. PubMed ID: 22375013
[TBL] [Abstract][Full Text] [Related]
39. RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors.
Martin RW; Orelli BJ; Yamazoe M; Minn AJ; Takeda S; Bishop DK
Cancer Res; 2007 Oct; 67(20):9658-65. PubMed ID: 17942895
[TBL] [Abstract][Full Text] [Related]
40. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
